NESS ZIONA, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today provided an update following the unblinding of clinical data from its vehicle-controlled proof-of-concept Phase 1b study of SGT-210 on Darier disease. Following unblinding, the data from the vehicle-controlled Phase 1b proof-of-concept study did not show differentiation between SGT-210 and vehicle on the study’s ...

Ellison Family Has Still Not Provided an Equity Backstop, Despite Headline Claims WBD Board's Full, Fair and Transparent Review Established a Level Playing Field in a Competitive Process Reiterates Recommendation in Support of Netflix Combination, Which Represents Superior, More Certain Value for Shareholders No Material Difference in Regulatory Risk Between PSKY Offer and Netflix Merger Paramount Offer Reflects Inadequate Value and Imposes Numerous, Significant Risks and Costs on WBD Illusory, Non-Binding ...

MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has issued a notice of partial redemption for US$500 million aggregate principal amount of its outstanding 6.000% Senior Notes due 2028 (the “2028 Notes”). As set forth in the notice of partial redemption issued today in respect of the 2028 Notes, the redemption date is February 15, 2026, and the redemption price for the 2028 Notes is 100% of the principal amount redeemed, plus accrued and unpaid interest. Thi ...

Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product Partner’s Program Size Positions it to Become a Top Five Commercial Customer for Lifecore CHASKA, Minn., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has signed a CDMO master services agreement with a new large global pharm ...

Toronto, Ontario--(Newsfile Corp. - December 17, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company") concludes 2025 having delivered a year of disciplined execution across technology development, global investor engagement, and strategic advancement—positioning the Company for a pivotal growth phase in 2026 at the convergence of artificial intelligence, quantum-inspired computation, and digital healthcare.Throughout 2025, Predictmedix AI enhanced the per ...

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - Orestone Mining Corp. (TSXV: ORS) (FSE: O2R2) ("Orestone" or the "Company") is pleased to announce the completion of its non-brokered private placement originally announced October 10, 2025 and updated October 14, 2025 and October 30, 2025. The Company issued 28,000,000 units ("Units") at a price of $0.08 per Unit for gross proceeds of $2,240,000. Each Unit consisted of one common share of the Company ("Common Share") and one common share ...

VANCOUVER, BC / ACCESS Newswire / December 17, 2025 / Gold Terra Resource Corp. (TSXV:YGT)(Frankfurt:TX0)(OTCQX:YGTFF) ("Gold Terra" or the "Company") is pleased to outline the Company's key achievements from the past year as it looks ahead to numerous catalysts in 2026. Over the past 12 months, Gold Terra has delivered a series of strategic advancements across exploration, financing, and key strategic investor support. ...

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - Elysee Development Corp. (TSXV: ELC) (FSE: QLDN) (the "Company") announces that it provided notice to the holders of its 8% unsecured convertible debentures (the "Debentures") that it would prepay its obligations under the Debentures on December 16, 2025. As such, the Company has proceeded with such prepayment and paid an aggregate of $2,106,250 plus accrued interest to such holders, settling Debentures with an aggregate principal amount o ...

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR PUBLICATION, RELEASE OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BC / ACCESS Newswire / December 17, 2025 / Alset AI Ventures Inc. (TSXV:GPUS)(OTC PINK:GPUSF)(FSE:1R60)(WKN:A40M0J) ("Alset AI" or the "Company"),an artificial intelligence ("AI") venture company advancing innovation through strategic investment and cloud computing solutions, is pleased to announce a non-brokere ...

License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applicationsCollaboration supports Sagimet’s fixed-dose combination (FDC) program currently in clinical developmentSagimet’s Phase 1 pharmacokinetic (PK) trial of combination of denifanstat and resmetirom is underway with topline data anticipated by the end of 2025Sagimet anticipates selecting one of the innovative forms of resmeti ...